Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Transplantation Proceedings|June 11, 2010
Reticulated platelets and platelet reactivity in renal transplant recipients receiving antiplatelet therapyM Zanazzi, F Cesari, G Rosso, et al.Transplantation Proceedings|May 23, 2009
Posttransplant proteinuria associated with everolimusE Bertoni, M Bruschi, G Candiano, et al.Transplantation Proceedings|April 26, 2005
Efficacy and safety of Palmaz stent implantation in the treatment of renal artery stenosis in renal transplantationM Salvadori, L Di Maria, A Rosati, et al.Transplantation Proceedings|June 11, 2010
Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk?S Farsetti, M Zanazzi, L Caroti, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Risk factors for cardiovascular disease in renal transplant recipients: new insightsR Marcucci, M Zanazzi, E Bertoni, et al.Transplantation Proceedings|June 11, 2010
Blood rheology and renal transplantation: an intriguing relationship for assessing cardiovascular riskM Zanazzi, C Fatini, S Farsetti, et al.Drugs in R&D|May 25, 2025
An Exploratory Pharmacogenetic Pilot Study of Two Reverse Transcriptase Inhibitors, Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil FumarateDerek E Murrell, Benjamin C Kennard, Maria E Bertoni, et al.Journal of Nephrology|April 3, 2001
Hyperhomocysteinemia in renal transplant patients: an independent factor of cardiovascular diseaseE Bertoni, R Marcucci, M Zanazzi, et al.Transplantation Proceedings|June 8, 2006
Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational studyM Salvadori, A Rosati, E Bertoni, et al.Clinical Transplantation|June 1, 1997
Regional vs. national renal sharing organizations: pros and consE Bertoni, M Carmellini, S Bandini, et al.Pageof 6